Fresenius Kabi Oncology Ltd. - Research Center
FKONCO Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 13 |
Mar ' 13 |
Sep ' 12 |
Mar ' 12 |
Sep ' 11 |
Sales |
223.01 |
298.28 |
298.02 |
250.11 |
274.20 |
Operating profit |
-20.40 |
72.66 |
70.34 |
27.50 |
41.69 |
Interest |
2.64 |
-9.79 |
7.19 |
7.50 |
7.31 |
Gross profit |
-22.18 |
83.27 |
64.13 |
20.55 |
35.22 |
EPS (Rs) |
-2.53 |
2.57 |
2.53 |
0.40 |
3.50 |
Half yearly
results in details
|
Sep ' 13 |
Mar ' 13 |
Sep ' 12 |
Mar ' 12 |
Sep ' 11 |
Other income |
0.86 |
0.82 |
0.98 |
0.54 |
0.85 |
Stock adjustment |
-6.52 |
-15.69 |
-15.33 |
-6.37 |
12.39 |
Raw material |
70.63 |
80.59 |
111.14 |
105.66 |
100.40 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
35.59 |
34.56 |
35.76 |
32.13 |
28.85 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
50.04 |
57.21 |
37.82 |
31.61 |
12.18 |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
93.68 |
68.94 |
58.29 |
59.58 |
78.70 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
14.44 |
13.22 |
12.56 |
12.31 |
11.66 |
Taxation |
3.37 |
22.64 |
11.58 |
4.70 |
5.47 |
Net profit / loss |
-39.99 |
40.60 |
39.99 |
6.28 |
55.31 |
Extra ordinary item |
- |
-6.81 |
- |
2.75 |
37.21 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
15.82 |
15.82 |
15.82 |
15.82 |
15.82 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
300.63 |
300.63 |
158.23 |
158.23 |
158.23 |
Agg.of non promotoholding (%) |
19.00 |
19.00 |
10.00 |
10.00 |
10.00 |
OPM (%) |
-9.15 |
24.36 |
23.60 |
11.00 |
15.20 |
GPM (%) |
-9.91 |
27.84 |
21.45 |
8.20 |
12.80 |
NPM (%) |
-17.86 |
13.57 |
13.37 |
2.51 |
20.11 |